Dr. Nibal Saad
Claim this profileMemorial Hospital of South Bend
Studies Lung Cancer
Studies Cancer
22 reported clinical trials
56 drugs studied
Area of expertise
1Lung Cancer
Stage IV
Stage III
Stage II
2Cancer
Stage IV
PD-L1 positive
Stage III
Affiliated Hospitals
Clinical Trials Nibal Saad is currently running
Olaparib
for Pancreatic Cancer
This phase II trial investigates how well the addition of olaparib following completion of surgery and chemotherapy works in treating patients with pancreatic cancer that has been surgically removed (resected) and has a pathogenic mutation in BRCA1, BRCA2, or PALB2. Olaparib is an inhibitor of PARP, an enzyme that helps repair deoxyribonucleic acid (DNA) when it becomes damaged. Blocking PARP may help keep tumor cells from repairing their damaged DNA, causing them to die. PARP inhibitors are a type of targeted therapy.
Recruiting0 awards Phase 232 criteria
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting2 awards Phase 327 criteria
More about Nibal Saad
Clinical Trial Related8 years of experience running clinical trials · Led 22 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Nibal Saad has experience with
- Biospecimen Collection
- Pembrolizumab
- Nivolumab
- Irinotecan Hydrochloride
- Trastuzumab
- Paclitaxel
Breakdown of trials Nibal Saad has run
Lung Cancer
Cancer
Pancreatic Cancer
Colorectal Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Nibal Saad specialize in?
Nibal Saad focuses on Lung Cancer and Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is Nibal Saad currently recruiting for clinical trials?
Yes, Nibal Saad is currently recruiting for 4 clinical trials in South Bend Indiana. If you're interested in participating, you should apply.
Are there any treatments that Nibal Saad has studied deeply?
Yes, Nibal Saad has studied treatments such as Biospecimen Collection, Pembrolizumab, Nivolumab.
What is the best way to schedule an appointment with Nibal Saad?
Apply for one of the trials that Nibal Saad is conducting.
What is the office address of Nibal Saad?
The office of Nibal Saad is located at: Memorial Hospital of South Bend, South Bend, Indiana 46601 United States. This is the address for their practice at the Memorial Hospital of South Bend.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.